Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
34.12
-0.38 (-1.10%)
At close: Jul 23, 2025, 2:57 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Lipoic Acid Series | 374.87M | Log In | Log In | Log In | Log In | Upgrade |
Lipoic Acid Series Growth | -17.38% | Log In | Log In | Log In | Log In | Upgrade |
Carnosine Series | 59.88M | Log In | Log In | Log In | Log In | Upgrade |
Carnosine Series Growth | 13.56% | Log In | Log In | Log In | Log In | Upgrade |
Phosphatidylcholine Series | 41.62M | Log In | Log In | Log In | Log In | Upgrade |
Phosphatidylcholine Series Growth | 2.91% | Log In | Log In | Log In | Log In | Upgrade |
Irecoxib | 6.74M | Log In | Log In | Log In | Log In | Upgrade |
Irecoxib Growth | 231.99% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 6.19M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | -67.86% | Log In | Log In | Log In | Log In | Upgrade |
Granular Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
Granular Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
GPC - Liquid | - | Log In | Log In | Log In | Log In | Upgrade |
GPC - Liquid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
L-Carnosine | - | Log In | Log In | Log In | Log In | Upgrade |
L-Carnosine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ethyl Dichlorooctanoate | - | Log In | Log In | Log In | Log In | Upgrade |
Ethyl Dichlorooctanoate Growth | - | Log In | Log In | Log In | Log In | Upgrade |
High Purity Solvent-free Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
High Purity Solvent-free Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid Tromethamine | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid Tromethamine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Others - Lipoic Acid Series | - | Log In | Log In | Log In | Log In | Upgrade |
Others - Lipoic Acid Series Growth | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
R-Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
API Alpha Lipoic Acid | - | Log In | Log In | Log In | Log In | Upgrade |
API Alpha Lipoic Acid Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Abroad | 307.89M | Log In | Log In | Log In | Log In | Upgrade |
Abroad Growth | -16.93% | Log In | Log In | Log In | Log In | Upgrade |
China | 181.40M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -8.19% | Log In | Log In | Log In | Log In | Upgrade |
Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
America | - | Log In | Log In | Log In | Log In | Upgrade |
America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Africa | - | Log In | Log In | Log In | Log In | Upgrade |
Africa Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Oceania | - | Log In | Log In | Log In | Log In | Upgrade |
Oceania Growth | - | Log In | Log In | Log In | Log In | Upgrade |